CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Total Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹23,249 Cr | ₹19,392 Cr | ₹16,805 Cr | ₹14,711 Cr | ₹13,181 Cr |
What is the latest Total Current Assets ratio of CIPLA ?
| Year | Total Current Assets |
|---|---|
| Mar2025 | ₹23,249 Cr |
| Mar2024 | ₹19,392 Cr |
| Mar2023 | ₹16,805 Cr |
| Mar2022 | ₹14,711 Cr |
| Mar2021 | ₹13,181 Cr |
How is Total Current Assets of CIPLA Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹23,249 Cr | 19.89 | |
| Mar2024 | ₹19,392 Cr | 15.40 | |
| Mar2023 | ₹16,805 Cr | 14.24 | |
| Mar2022 | ₹14,711 Cr | 11.61 | |
| Mar2021 | ₹13,181 Cr | - | |
Compare Total Current Assets of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹101,447.6 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,470.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,996.0 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,440.0 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,417.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| MANKIND PHARMA | ₹82,555.3 Cr | -4.4% | -3.6% | -7.9% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -3.3% |
-6.9% |
-17% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses